Absence of Grail promotes CD8+ T cell anti-tumour activity
Grail is an E3 ubiquitin ligase that inhibits T-cell receptor signalling in CD4+ T cells. Here the authors show Grail also limits IL-21 receptor expression and function in CD8+ T cells, is overactive in these cells in patients with lymphoma, and promotes tumour development in a lymphoma transplant m...
Guardado en:
Autores principales: | Cara Haymaker, Yi Yang, Junmei Wang, Qiang Zou, Anupama Sahoo, Andrei Alekseev, Divyendu Singh, Krit Ritthipichai, Yared Hailemichael, Oanh N. Hoang, Hong Qin, Kimberly S. Schluns, Tiejun Wang, Willem W. Overwijk, Shao-Cong Sun, Chantale Bernatchez, Larry W. Kwak, Sattva S. Neelapu, Roza Nurieva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4450d2168a5641f593a18e67e984d580 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Patched Local Lunar Gravity Solutions Using GRAIL Data
por: Sander Goossens, et al.
Publicado: (2021) -
The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail
por: Butalia S, et al.
Publicado: (2020) -
Translating the Hebrew Psalms to be Sung: The 2010 Revised Grail Psalms, a Case Study
por: Danny Fitzgerald
Publicado: (2021) -
Is transcranial focused ultrasound stimulation (tFUS) the next holy grail for treating depression?
por: Mark George, et al.
Publicado: (2021) -
Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues
por: Edwin R. Parra, et al.
Publicado: (2017)